Heart failure

Main article: Human heart

Heart failure - a severe disease with a high level of hospitalization and serious mortality rates - is regarded by specialists as one of the main problems of the health care system in modern society. According to studies, one in three patients with CHF is hospitalized, and one in two dies within 5 years after diagnosis.

Disease statistics

According to August 2020, heart failure in the world affects approximately 64 million people. Half of heart failure patients die within five years of diagnosis, so the disease remains as deadly as some of the most common cancers.

In Russia, as of November 2020, mortality from diseases of the circulatory system is 46.7% of deaths from all causes. Chronic heart failure (CHF) is the leader in the structure of mortality from diseases of the circulatory system, which is regarded as one of the main problems of the health care system in modern society. In Russia, about 10 million people suffer from this disease.

Diabetes mellitus and CHF are interdependent diseases: the presence of one repeatedly increases the risk of developing another. As of November 2020, the prevalence of CHF in patients with type 2 DM ranges from 24% to 40%.

Symptoms

The symptoms of HF may be nonspecific and a medical visit is required to diagnose it. Patients often live with heart failure for many months before being appropriately diagnosed, and symptoms of heart failure in primary care settings are often undiagnosed, resulting in patients being hospitalized.

Treatment technologies

2023: Intracardiac pressure control device presented without chest piercing

On November 8, 2023, Swedish startup Acorai introduced non-invasive pressure measurement technology in the heart chambers. A sensory system called Save is designed to simplify and make more effective the treatment of heart failure. Read more here.

2022

A smart belt has been developed that detects the progression of heart failure

In late December 2022, researchers at Florida Atlantic University unveiled a belt that can track heart failure patients for signs of disease progression. Read more here.

Presented is an apparatus for the treatment of heart and pulmonary failure

On July 11, 2022, Inspira Technologies introduced the Liby system for the treatment of heart and lung failure. She uses an invasive extracorporeal method of oxygen saturation in the development of severe acute respiratory failure. Read more here.

2019: Worldwide heart failure prevalence rises 29% in 10 years

In the period from 2010 to 2019, the global prevalence of heart failure increased by 29%. By the end of this period, approximately 56.2 million people suffered from this ailment worldwide. Such data are reflected in a study by an international group of scientists, the results of which were published at the end of June 2024.

It is said that the prevalence of heart failure is gradually increasing worldwide, which can be explained by an aging population and an increase in risk factors. The highest incidence rates are observed in East Asia, North America and Western Europe.

In the US, the prevalence of heart failure among adults is estimated at 2.5%, whereas in Canada the rate was 3.5% in 2022. In Europe, the prevalence was at 1.7% in 2019: in this region, the highest values ​ ​ were recorded in Germany and Lithuania, and the lowest - in Greece, the Netherlands, Spain and Britain. In the US, heart failure with a preserved ejection fraction occurs in about 50% of cases, while in Europe the disease with a reduced ejection fraction prevails.

In general, as the study says, the incidence of heart failure is decreasing on a global scale. The reduction varies substantially between regions and demographics. In the United States, the number of patients with heart failure aged 65 years and older decreased from 36 cases per 1000 people in 2011 to 26 cases per 1000 residents in 2016. In the US and Europe, women have a higher incidence of heart failure compared to men. In addition, European women are more likely than men to have heart failure with a preserved ejection fraction.^[1]

Notes